Drug interactions
Arformoterol + Bumetanide
Severity: Moderate
Arformoterol and Bumetanide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Bumetanide causes renal potassium loss, and arformoterol moves potassium into cells. Together they can produce significant hypokalemia, which may precipitate arrhythmias in patients with cardiac disease.
What this interaction means in plain words
Arformoterol and Bumetanide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Arformoterol belongs to Respiratory; Bumetanide belongs to Cardiovascular.
Why it happens
Additive hypokalemia from renal potassium wasting and beta-2 mediated intracellular potassium shift.
What to do
Monitor serum potassium and magnesium, especially at initiation and in patients with heart disease. Replace potassium as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Arformoterol and Bumetanide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Bumetanide
Other interactions of Arformoterol
Frequently asked questions
Can I take Arformoterol with Bumetanide?
MediHelp rates the interaction as moderate. Arformoterol and Bumetanide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Bumetanide causes renal potassium loss, and arformoterol moves potassium into cells. Together they can produce significant hypokalemia, which may precipitate arrhythmias in patients with cardiac disease.
How serious is the interaction between Arformoterol and Bumetanide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium and magnesium, especially at initiation and in patients with heart disease. Replace potassium as needed.
What other medicines interact with Bumetanide?
MediHelp also lists interactions of Bumetanide with, for example, Amifostine, Amikacin, Captopril-hydrochlorothiazide. The full list is on the Bumetanide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
